Execution: Project Lead Digital Twin
A customer wanted to evaluate a new technology to test pharmaceutical substances "insilico", i.e. digitally through simulation, before the first clinical tests. Data from the previously performed laboratory tests were to be used. Models of the human heart were created in a supercomputer environment. These were used to assess possible side effects on the human heart.
The data were compared to clinical trials for several existing drugs. A real substance from drug research was also simulated. The new tool is now being used operationally by the company. A publication from the pharmaceutical company and the startup partner has been submitted.